La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)  Facettes :

List of bibliographic references indexed by Parkinson Disease (drug therapy)

Number of relevant bibliographic references: 472.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000121 (2016) R. Magnard [France] ; Y. Vachez [France] ; C. Carcenac [France] ; P. Krack [France] ; O. David [France] ; M. Savasta [France] ; S. Boulet [France] ; S. Carnicella [France]What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?
000137 (2016) Santiago Perez-Lloret [Argentine] ; Olivier Rascol [France]The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.
000182 (2016) Leslie Mazuel [France] ; Carine Chassain [France] ; Betty Jean [France] ; Bruno Pereira [France] ; Aurélie Cladière [France] ; Claudine Speziale [France] ; Franck Durif [France]Proton MR Spectroscopy for Diagnosis and Evaluation of Treatment Efficacy in Parkinson Disease.
000199 (2016) Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France]Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
000354 (2016) Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie]Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000365 (2016) Caroline Moreau [France] ; David Devos [France] ; Luc Defebvre [France]Acetylcholinesterase inhibitors and gait: a steadying hand?
000373 (2016) N. Simon [France] ; F. Viallet [France] ; A. Boulamery [France] ; A. Eusebio [France] ; D. Gayraud [France] ; J-P Azulay [France]A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.
000455 (2015) Maude Beaudoin-Gobert [France] ; Léon Tremblay [France] ; Véronique Sgambato-Faure [France][An implication of serotonergic fibers which goes beyond Levodopa-induced dyskinesia].
000481 (2015) Michael R. Paillasse [France] ; Philippe De Medina [France]The NR4A nuclear receptors as potential targets for anti-aging interventions.
000487 (2015) Nikhil M. Urs ; Simone Bido [France] ; Sean M. Peterson ; Tanya L. Daigle ; Caroline E. Bass ; Raul R. Gainetdinov [Russie] ; Erwan Bezard [France] ; Marc G. CaronTargeting β-arrestin2 in the treatment of l-DOPA–induced dyskinesia in Parkinson’s disease
000488 (2015) Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Philippe Gorry [France] ; Serge Przedborski [États-Unis] ; Miquel Vila [Espagne] ; Stephane Hunot [France] ; Andrew Singleton [États-Unis] ; C. Warren Olanow [États-Unis] ; Kalpana M. Merchant [États-Unis] ; Erwan Bezard [France] ; Gregory A. Petsko [États-Unis] ; Wassilios G. Meissner [France]Targeting α-synuclein for treating Parkinson’s disease: mechanistic and therapeutic considerations
000489 (2015) Marianne Amalric [France]Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.
000498 (2015) Mathieu Anheim [France] ; Patricia Dowsey-Limousin [France] ; Paul Krack [France] ; Stéphan Chabardès [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Subthalamic stimulation or subthalamic lesion for Parkinson's disease? A case report.
000511 (2015) Romain Lefaucheur [France] ; Floriane Le Goff [France] ; Gaëlle Gaillon [France] ; Aude Triquenot-Bagan [France] ; David Maltête [France]Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
000515 (2015) Emma D. Deeks [Oman]Safinamide: first global approval.
000535 (2015) Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis]Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
000537 (2015) Caroline Moreau [France] ; Sayah Meguig [France] ; Jean-Christophe Corvol [France] ; Julien Labreuche [France] ; Francis Vasseur [France] ; Alain Duhamel [France] ; Arnaud Delval [France] ; Thomas Bardyn [France] ; Jean-Christophe Devedjian [France] ; Nathalie Rouaix [France] ; Gregory Petyt [France] ; Christine Brefel-Courbon [France] ; Fabienne Ory-Magne [France] ; Dominique Guehl [France] ; Alexandre Eusebio [France] ; Valérie Fraix [France] ; Pierre-Jean Saulnier [France] ; Ouhaid Lagha-Boukbiza [France] ; Frank Durif [France] ; Mirela Faighel [France] ; Caroline Giordana [France] ; Sophie Drapier [France] ; David Maltête [France] ; Christine Tranchant [France] ; Jean-Luc Houeto [France] ; Bettina Debû [France] ; Jean-Philippe Azulay [France] ; François Tison [France] ; Alain Destée [France] ; Marie Vidailhet [France] ; Olivier Rascol [France] ; Kathy Dujardin [France] ; Luc Defebvre [France] ; Régis Bordet [France] ; Bernard Sablonnière [France] ; David Devos [France]Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
000543 (2015) Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000551 (2015) Marie-Laure Welter [France] ; Adele Demain ; Claire Ewenczyk ; Virginie Czernecki ; Brian Lau ; Amine El Helou ; Hayat Belaid ; Jérôme Yelnik ; Chantal François ; Eric Bardinet ; Carine Karachi ; David GrabliPPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study.
000562 (2015) Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal]New treatments for levodopa-induced motor complications.
000570 (2015) Audrey Maillet [France] ; Stéphane Thobois ; Valérie Fraix ; Jérôme Redouté ; Didier Le Bars ; Franck Lavenne ; Philippe Derost ; Franck Durif ; Bastiaan R. Bloem ; Paul Krack ; Pierre Pollak ; Bettina DebûNeural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024